60 Degrees Pharmaceuticals develops and commercializes new medicines to treat and prevent infectious diseases.
60 Degrees Pharma has raised $5.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in July 2025.
60 Degrees Pharma is headquartered in Washington, United States.
60 Degrees Pharmaceuticals develops and commercializes new medicines to treat and prevent infectious diseases.
60 Degrees Pharma is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"60 Degrees Pharma — Funding & Investors." VCBacked, July 15, 2025, https://www.vcbacked.co/company/60-degrees-pharma. Accessed September 30, 2026.
VCBacked. (2025). 60 Degrees Pharma — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/60-degrees-pharma
{{cite web |title=60 Degrees Pharma — Funding & Investors |url=https://www.vcbacked.co/company/60-degrees-pharma |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated